104 related articles for article (PubMed ID: 14655279)
1. [The comet assay: principles of the method and clinical utilization].
Novotná B; Neuwirtová R; Blazková V; Sisková M
Cas Lek Cesk; 2001 Dec; 140(24):761-6. PubMed ID: 14655279
[TBL] [Abstract][Full Text] [Related]
2. DNA instability in low-risk myelodysplastic syndromes: refractory anemia with or without ring sideroblasts.
Novotna B; Neuwirtova R; Siskova M; Bagryantseva Y
Hum Mol Genet; 2008 Jul; 17(14):2144-9. PubMed ID: 18430715
[TBL] [Abstract][Full Text] [Related]
3. Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome.
Novotna B; Bagryantseva Y; Siskova M; Neuwirtova R
Leuk Res; 2009 Feb; 33(2):340-3. PubMed ID: 18687469
[TBL] [Abstract][Full Text] [Related]
4. Genotoxicity of environmental agents assessed by the alkaline comet assay.
Møller P
Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009
[TBL] [Abstract][Full Text] [Related]
5. Single-cell gel electrophoresis assay monitors precise kinetics of DNA fragmentation induced during programmed cell death.
Chandna S
Cytometry A; 2004 Oct; 61(2):127-33. PubMed ID: 15382149
[TBL] [Abstract][Full Text] [Related]
6. Limited numbers of apoptotic cells in fresh paraffin embedded bone marrow samples of patients with myelodysplastic syndrome.
Brada SJ; van de Loosdrecht AA; Koudstaal J; de Wolf JT; Vellenga E
Leuk Res; 2004 Sep; 28(9):921-5. PubMed ID: 15234568
[TBL] [Abstract][Full Text] [Related]
7. UVA-induced apoptosis studied by the new apo/necro-Comet-assay which distinguishes viable, apoptotic and necrotic cells.
Morley N; Rapp A; Dittmar H; Salter L; Gould D; Greulich KO; Curnow A
Mutagenesis; 2006 Mar; 21(2):105-14. PubMed ID: 16500949
[TBL] [Abstract][Full Text] [Related]
8. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
[TBL] [Abstract][Full Text] [Related]
9. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
[TBL] [Abstract][Full Text] [Related]
11. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
[TBL] [Abstract][Full Text] [Related]
12. [Study on apoptosis in myelodysplastic syndromes by DNA in situ end labelling combined with APAAP].
Li X; Pu Q; Liu Y; Shi J; Tao Y; Chang C; Jiang Q; Huang W
Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):27-9. PubMed ID: 12015085
[TBL] [Abstract][Full Text] [Related]
13. The comet assay: a sensitive genotoxicity test for the detection of DNA damage.
Speit G; Hartmann A
Methods Mol Biol; 2005; 291():85-95. PubMed ID: 15502214
[TBL] [Abstract][Full Text] [Related]
14. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow mononuclear cells of MDS patients are characterized by in vitro proliferation and increased apoptosis independently of stromal interactions.
Span LF; Rutten E; Gemmink A; Boezeman JB; Raymakers RA; de Witte T
Leuk Res; 2007 Dec; 31(12):1659-67. PubMed ID: 17659774
[TBL] [Abstract][Full Text] [Related]
16. The comet assay: a method to measure DNA damage in individual cells.
Olive PL; Banáth JP
Nat Protoc; 2006; 1(1):23-9. PubMed ID: 17406208
[TBL] [Abstract][Full Text] [Related]
17. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
[TBL] [Abstract][Full Text] [Related]
18. Could a strong alkali deproteinization replace the standard lysis step in alkaline single cell gel electrophoresis (comet) assay (pH>13)?
Vivek Kumar PR; Cheriyan VD; Seshadri M
Mutat Res; 2009 Aug; 678(1):65-70. PubMed ID: 19563911
[TBL] [Abstract][Full Text] [Related]
19. [Apoptotic characteristics of CD34 positive cells in myelodysplastic syndromes].
Li X; Pu Q; Liu YZ; Tao Y; Ying SX; Jiang QY; Shi J
Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):355-7. PubMed ID: 12941189
[TBL] [Abstract][Full Text] [Related]
20. Alkaline comet assay study with breast cancer patients: evaluation of baseline and chemotherapy-induced DNA damage in non-target cells.
Kopjar N; Milas I; Garaj-Vrhovac V; Gamulin M
Clin Exp Med; 2006 Dec; 6(4):177-90. PubMed ID: 17191110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
